公司的首席财务官于4月1日出售了120万美元股票. Nuvalent CFO sold $1.2M in stock on April 1.

据Nuvalent (NASDAQ:NUVL) 的报道,其首席财务官于4月1日出售了大约120万美元的股票,使他的股份减少了近12%. Nuvalent (NASDAQ: NUVL) reported that its Chief Financial Officer sold approximately $1.2 million in stock on April 1, reducing his stake by nearly 12%. 这家临床阶段的瘤公司周五股价高达105.43美元, 交易量很大. The clinical-stage oncology company saw its shares trade near $105.43 on Friday with high volume. 分析师们的共识是"中等买入",目标价137.25美元,尽管一些公司已经分配了"卖出"评级. Analysts have a "Moderate Buy" consensus rating with a target price of $137.25, though some firms have assigned a "sell" rating.